Quantifying the impact of hepatitis A immunization in the United States, 1995-2001

Vaccine

Volumn 22, Issue 31-32, 2004, Pages 4342-4350

  Samandari, Taraz ^a,b   Bell, Beth P ^a   Armstrong, Gregory L ^a,c  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c 1 West Court Square ^*  (United States)

Author keywords

Hepatitis A; Model; Vaccination

Indexed keywords

ARTICLE; CORRELATION ANALYSIS; HEPATITIS A; HERD IMMUNITY; HUMAN; IMMUNIZATION; INCIDENCE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REGRESSION ANALYSIS; STATISTICAL ANALYSIS; UNITED STATES;

ADULT; AGE FACTORS; ALGORITHMS; CHILD; HEPATITIS A; HEPATITIS A VACCINES; HUMANS; MASS IMMUNIZATION; MODELS, STATISTICAL; POPULATION SURVEILLANCE; UNITED STATES;

EID: 4944248353     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2004.04.014     Document Type: Article

References (17)

1. Center for Disease Control and Prevention Summary of notifiable diseases - United States, 2002. Morb Mortal Wkly Rep 2002;51:70-2.
2. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices. Morb Mortal Wkly Rep 1999;48(RR-12):25-6.
3. Averhoff F., Shapiro C.N., Bell B.P., Hymas I., Burd L., Deladizma A., et al. Control of hepatitis A through routine vaccination of children. J. Am. Med. Assoc. 286:2001;2968-2973
4. Innis B.L., Snitbhan R., Kunasol P., Laorakpongse T., Poopatanakool W., Kozik C.A., et al. Protection against hepatitis A by an inactivated vaccine. J. Am. Med. Assoc. 271:1994;1328-1334
5. Werzberger A., Mensch B., Kuter B., Brown L., Lewis J., Sitrin R., et al. A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children. N. Engl. J. Med. 327:1992;453-457
6. Van Herck K., Van Damme P. Inactivated hepatitis A vaccine-induced antibodies: follow-up and estimates of long-term persistence. J. Med. Virol. 63:2001;1-7
7. Ashur Y., Adler R., Rowe M., Shouval D. Comparison of immunogenicity of two hepatitis A vaccines - VAQTA and HAVRIX - in young adults. Vaccine. 17:1999;2290-2296
8. Van Damme P., Mathei C., Thoelen S., Meheus A., Safary A., Andre F.E. Single dose inactivated hepatitis A vaccine: rationale and clinical assessment of the safety and immunogenicity. J. Med. Virol. 44:1994;435-441
9. Setia S., Mainzer H., Washington M.L., Coil G., Snyder R., Weniger B.G. Frequency and causes of vaccine wastage. Vaccine. 20:2002;1148-1156
10. Centers for Disease Control and Prevention. Case definitions for public health surveillance. Morb Mortal Wkly Rep 1990;39(RR-13):17-8.
11. Staes C.J., Schlenker T.L., Risk I., Cannon K.E., Harris H., Pavia A.T., et al. Sources of infection among persons with acute hepatitis A and no identified risk factors during a sustained community-wide outbreak. Pediatrics. 106:2000;E54
12. Armstrong G.L., Bell B.P. Hepatitis A virus infections in the United States: model-based estimates and implications for childhood immunization. Pediatrics. 109:2002;839-845
13. Anderson RM, May RM. Infectious diseases of humans: dynamics and control. New York (NY): Oxford University Press Inc.; 1998.
14. Smith P.F., Grabau J.C., Werzberger A., Gunn R.A., Rolka H.R., Kondracki S.F., et al. The role of young children in a community-wide outbreak of hepatitis A. Epidemiol. Infect. 118:1997;243-252
15. Plotkin SA, Murdin A, Vidor E. Inactivated polio vaccine. In: Plotkin SA, Orenstein, WA, editors. Vaccines. Philadelphia: WB Saunders; 1999. p. 354-5.
16. Sutter RW, Cochi SL, Melnick, JL. Live attenuated poliovirus vaccines. In: Plotkin SA, Orenstein, WA, editors. Vaccines. Philadelphia: WB Saunders; 1999. p. 372.
17. Dagan RA, Leventhal E, Anis P, Slater P, Shouval D. National hepatitis A virus (HAV) immunization program aimed exclusively at toddlers in an endemic country resulting in >90% reduction in morbidity rate in all ages. Abstracts of the Infectious Diseases Society of America, 40th Annual Meeting, Chicago, IL, USA; 24-27 October 2002. Late-Breaker Session, paper 825.